Re: Hypofractionated Radiotherapy versus Conventionally Fractionated Radiotherapy for Patients with Intermediate-Risk Localised Prostate Cancer: 2-Year Patient-Reported Outcomes of the Randomised, Non-Inferiority, Phase 3 CHHiP Trial

Samir S. Taneja

doi:10.1016/j.juro.2016.08.067

Re: Hypofractionated Radiotherapy versus Conventionally Fractionated Radiotherapy for Patients with Intermediate-Risk Localised Prostate Cancer: 2-Year Patient-Reported Outcomes of the Randomised, Non-Inferiority, Phase 3 CHHiP Trial

Samir S. Taneja

Biomedical Engineering

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1445-1447
Number of pages	3
Journal	The Journal of urology
Volume	196
Issue number	5
DOIs	https://doi.org/10.1016/j.juro.2016.08.067
State	Published - Nov 1 2016

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.juro.2016.08.067

Cite this

Re: Hypofractionated Radiotherapy versus Conventionally Fractionated Radiotherapy for Patients with Intermediate-Risk Localised Prostate Cancer: 2-Year Patient-Reported Outcomes of the Randomised, Non-Inferiority, Phase 3 CHHiP Trial. / Taneja, Samir S.
In: The Journal of urology, Vol. 196, No. 5, 01.11.2016, p. 1445-1447.

Research output: Contribution to journal › Comment/debate › peer-review

@article{212418b61daa46c688cf390689709414,

title = "Re: Hypofractionated Radiotherapy versus Conventionally Fractionated Radiotherapy for Patients with Intermediate-Risk Localised Prostate Cancer: 2-Year Patient-Reported Outcomes of the Randomised, Non-Inferiority, Phase 3 CHHiP Trial",

author = "Taneja, {Samir S.}",

year = "2016",

month = nov,

day = "1",

doi = "10.1016/j.juro.2016.08.067",

language = "English (US)",

volume = "196",

pages = "1445--1447",

journal = "The Journal of urology",

issn = "0022-5347",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Re

T2 - Hypofractionated Radiotherapy versus Conventionally Fractionated Radiotherapy for Patients with Intermediate-Risk Localised Prostate Cancer: 2-Year Patient-Reported Outcomes of the Randomised, Non-Inferiority, Phase 3 CHHiP Trial

AU - Taneja, Samir S.

PY - 2016/11/1

Y1 - 2016/11/1

UR - http://www.scopus.com/inward/record.url?scp=85053073134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053073134&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2016.08.067

DO - 10.1016/j.juro.2016.08.067

M3 - Comment/debate

C2 - 27751451

AN - SCOPUS:85053073134

SN - 0022-5347

VL - 196

SP - 1445

EP - 1447

JO - The Journal of urology

JF - The Journal of urology

IS - 5

ER -

Re: Hypofractionated Radiotherapy versus Conventionally Fractionated Radiotherapy for Patients with Intermediate-Risk Localised Prostate Cancer: 2-Year Patient-Reported Outcomes of the Randomised, Non-Inferiority, Phase 3 CHHiP Trial

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this